Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Perth
Clinical trial register · Australia

Clinical Trials in Perth, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Children's Oncology Group23 National Cancer Institute (NCI)13 Eli Lilly and Company11 AbbVie10 Nationwide Children's Hospital7
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Perth

295 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
The University of Western Australia
Observational
40
Perth
2026-10
Not yet open
A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression
NCT07686445Solid Tumor (Phase I), RAS Mutation, CEACAM5
Adlai Nortye Biopharma Co., Ltd.
Phase 1
228
Perth, Sydney
2026-09-23
Recruiting
Evaluation of XYA02 in Patients With Advanced Solid Tumors
NCT07670312MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer, GEJ Adenocarcinoma
XYone Therapeutics, Inc
Phase 1/2
190
Sydney, Melbourne, Perth
2026-09-17
Recruiting
Bristol-Myers Squibb
Phase 2
160
Gosford, Westmead, Greenslopes, Heidelberg, Perth
2026-09-10
Not yet open
IBIS - Investigating Reliability of BIS and SEDLINE Monitoring in Children With Developmental and Epileptic Encephalopathies (DEE).
NCT07585643Epileptic Encephalopathy, Early Infantile Epileptic Encephalopathy, Infantile Spasm, Developmental and Epileptic Encephalopathies
Telethon Kids Institute
Observational
40
Perth
2026-09-03
Not yet open
ResMed
Observational
90
Adelaide, Woodville South, Perth, Heidelberg
2026-09
Recruiting
Context Therapeutics Inc.
Phase 1
162
Wahroonga, Westmead, Gold Coast, Newcastle, Heidelberg, Perth
2026-09
Recruiting
AstraZeneca
Phase 3
7,000
Castle Hill, Fitzroy, Gosford, Melbourne, Perth, Southport, St Leonards, Wollongong
2026-08-21
Not yet open
Sleep Quality - Comparing the Effect of Ondansetron or Dexamethasone Given as Routine Prophylaxis Intraoperatively to Prevent Post Operative Nausea and Vomiting (SCORPION)
NCT07777276Postoperative Sleep Quality, Postoperative Behaviour, Postoperative Recovery in Children, Postoperative Nausea and Vomiting (PONV)
DrugsOndansetron·Dexamethasone
Telethon Kids Institute
Phase 4
500
Perth
2026-08-17
Recruiting
Sitala Bio LTD
Phase 2
15
Newcastle, Penrith, Sydney, Woolloongabba, Clayton, Saint Albans, Perth
2026-08-04
Recruiting
VectivBio AG
Phase 3
124
Fitzroy, Heidelberg, Herston, Perth
2026-08
Recruiting
VelaVigo Bio Inc
Phase 1/2
230
St Leonards, Perth
2026-07-30
Recruiting
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
NCT07362446Myocardial Infarction, Reperfusion Injury, AMI, STEMI (ST Elevation MI)
Nyrada Pty Ltd
Phase 2
300
Kingswood, Liverpool, Adelaide, Epping, Frankston, Saint Albans, Nedlands, Perth
2026-07-02
Not yet open
East Metropolitan Health Service, Australia
Phase 2
10
Perth
2026-07
Recruiting
ViiV Healthcare
Phase 3
564
Darlinghurst, Sydney, Taringa, Perth
2026-06-25
Recruiting
Taiho Pharmaceutical Co., Ltd.
Phase 3
784
Brisbane, Melbourne, Perth, Sydney
2026-06-24
Recruiting
Imaging Study in Metastatic Clear Cell RCC.
NCT07671417Metastatic Clear Cell Renal Cell Carcinoma
RayzeBio, Inc.
Early Phase 1
10
Saint Leonards, Nedlands, Perth
2026-06-15
Recruiting
Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC
NCT07671092Metastatic Urothelial Carcinoma, Breast Cancer, TNBC - Triple-Negative Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer
RayzeBio, Inc.
Early Phase 1
40
St Leonards, Nedlands, Perth
2026-06-15
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Darlinghurst, Garran, Heidelberg, Macquarie University, Melbourne, Perth, Port Macquarie
2026-05-31
Recruiting
Shanghai Argo Biopharmaceutical Co., Ltd.
Phase 1
40
Perth
2026-05-29
Recruiting
Pfizer
Phase 2
24
Westmead, Clayton, Perth
2026-05-28
Recruiting
First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer
NCT07608848Metastatic Breast Cancer, Metastatic Prostate Cancer, GRPR-Targeted Molecular Imaging, Theranostic Radiopharmaceuticals
Integrated Haematology and Oncology Network
Early Phase 1
20
Perth
2026-05-28
Recruiting
Shanghai Henlius Biotech
Phase 1
258
Perth
2026-05-25
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Blacktown, Macquarie Park, Clayton, Geelong, Melbourne, St Albans, Perth
2026-05-21
Recruiting
AbbVie
Phase 1
18
Westmead, Perth
2026-05-20
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Camperdown, Liverpool, Chemside, Woolloongabba, Clayton, Perth
2026-05-11
Recruiting
AstraZeneca
Phase 3
420
Adelaide, Fitzroy, Heidelberg, Nedlands, Perth, Rockingham
2026-05-05
Recruiting
Incyte Corporation
Phase 3
588
Macquarie Park, Chermside, Townsville, Woodville South, Melbourne, Richmond, Canberra, Perth
2026-04-09
Recruiting
TrueLab Biopharmaceutical Co., Ltd
Phase 1
48
Perth
2026-04-08
Not yet open
Study of Min-Max APAP Recommender Tool
NCT07400861Obstructive Sleep Apnea (OSA)
ResMed
Not applicable
90
Perth
2026-04-01
Recruiting
Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks)
Phase 1
30
Perth
2026-03-20
Recruiting
Priovant Therapeutics, Inc.
Phase 2/3
342
Adelaide, Perth, Sydney
2026-03-19
Recruiting
Uppsala University
Observational
2,000
Perth
2026-03-01
Recruiting
Hoffmann-La Roche
Phase 2
80
Blacktown, Coffs Harbour, Bendigo, Perth
2026-02-18
Recruiting
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
NCT07349212Peanut-Induced Anaphylaxis, Peanut Allergy
Ukko Inc
Phase 1/2
40
Camperdown, Bedford Park, Fitzroy, Perth
2026-02-18
Recruiting
Eli Lilly and Company
Phase 3
300
Adelaide, Brisbane, Heidelberg West, Ipswich, Melbourne, Oaklands Park, Parkville, Perth
2026-02-05
Active, closed
Medtronic MiniMed, Inc.
Not applicable
389
New Lambton, Sydney, Perth
2026-02-02
By invitation
Immunovant Sciences GmbH
Phase 2
372
South Brisbane, Southport, Perth, St Leonards, Sydney
2026-01-26
Recruiting
CSL Behring
Phase 2
84
Chandler, Brisbane, Clayton, Perth, Westmead
2026-01-22
Recruiting
Eli Lilly and Company
Phase 3
150
Adelaide, Box Hill, Brisbane, Melbourne, Parkville, Perth, Randwick, Westmead
2026-01-12
Recruiting
AstraZeneca
Phase 1/2
84
Fitzroy, Perth
2026-01-09
Recruiting
Telethon Kids Institute
Not applicable
500
Perth
2026-01-08
Active, closed
Atridia Pty Ltd.
Early Phase 1
40
Perth
2026-01-05
Recruiting
Regeneron Pharmaceuticals
Phase 3
915
Benowa, Brisbane, Southport, Melbourne, Perth
2026-01-02
Recruiting
Arrowhead Pharmaceuticals
Phase 1/2
78
Charlestown, Morayfield, East Melbourne, Melbourne, Perth, Clayton
2025-12-22
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Box Hill, Brisbane, Campbelltown, Heidelberg, Macquarie University, Perth, Randwick, St Albans
2025-12-12
Recruiting
Restera, Inc.
Not applicable
20
Perth
2025-12
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Ballarat Central, Bendigo, Perth, Shepparton, Traralgon
2025-11-28
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Kingswood, Kogarah, Randwick, South Brisbane, Melbourne, Nedlands, Perth, Gosford
2025-11-25
Recruiting
Neurotech Pharmaceuticals
Phase 4
234
East Melbourne, Perth, Sydney
2025-11-21
Recruiting
Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
NCT07100730Neoplastic Disease, Glioblastoma, Glioblastoma (GBM), Glioblastoma Multiform
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
50
Gold Coast, Melbourne, Perth, Adelaide
2025-11-02
Not yet open
Nyxoah S.A.
Observational
39
Sydney, Brisbane, Melbourne, Perth
2025-11
Recruiting
Eli Lilly and Company
Phase 3
1,205
Box Hill, Brisbane, Canberra, Geelong, Meadowbrook, Perth, Southport, St Leonards
2025-10-31
Recruiting
RAPT Therapeutics, Inc., a member of the GSK plc group of companies
Phase 2
100
Darlinghurst, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Nedlands, Perth
2025-10-22
Recruiting
TLN-372 in Advanced KRAS Mutant Solid Tumors
NCT07204340KRAS Mutant Solid Tumors
DrugsCetuximab·Pembrolizumab
Treeline Biosciences, Inc.
Phase 1
270
Melbourne, Perth
2025-09-29
Recruiting
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
NCT07115953Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
130
Melbourne, Perth
2025-09-22
By invitation
Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).
NCT07177612Lipoprotein(a), Lipoprotein(a), Hyper-Lp(a)-Emia
Changi General Hospital
Observational
20,000
Perth
2025-09-09
Recruiting
Treatable Traits in Interstitial Lung Disease
NCT06626438Interstitial Lung Diseases (ILD)
The University of Western Australia
Not applicable
110
Perth
2025-09-03
Active, closed
Atridia Pty Ltd.
Phase 1
24
Perth
2025-08-19
Recruiting
AstraZeneca
Phase 3
250
Brisbane, Clayton, Perth
2025-08-07
Recruiting
Sanofi
Phase 3
723
Brisbane, Adelaide, Perth
2025-08-06
Recruiting
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
NCT06333899High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Infant Type Hemispheric Glioma
DrugLorlatinib
Nationwide Children's Hospital
Early Phase 1
15
Randwick, South Brisbane, Perth
2025-08-03
Not yet open
Virtual Reality for Vocational Recovery
NCT07114887Mental Health Disorder
Orygen
Not applicable
20
Orange, Melbourne, Perth
2025-08
Recruiting
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
NCT07047703Axial Spondyloarthritis (AxSpA)
Grey Wolf Therapeutics
Phase 1/2
140
Birtinya, Morayfield, Perth, Sydney
2025-07-28
Recruiting
Celgene
Phase 3
400
Westmead, Adelaide, Hobart, Heidelberg, Malvern, Perth
2025-07-28
Recruiting
Daiichi Sankyo
Phase 2
130
Adelaide, Australia, Darlinghurst, Melbourne, Perth, Southport, Sydney
2025-07-18
Recruiting
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
NCT06974110Advanced Solid Tumor, Metastatic Solid Tumor, Endometrial Cancer, MSI-H Cancer
DrugIrinotecan
MOMA Therapeutics
Phase 1
132
Sydney, Westmead, Woolloongabba, Adelaide, Clayton, Perth
2025-07-16
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798Systemic Lupus Erythematosus, Active Refractory Rheumatoid Arthritis
DrugsUplizna·Inebilizumab·Blinatumomab
Amgen
Phase 2
220
Perth
2025-07-16
Recruiting
Bristol-Myers Squibb
Phase 3
586
Kogarah, Macquarie Park, Carlton, Perth, Darlinghurst
2025-07-14
Recruiting
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
NCT06838676Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG, Refractory DIPG, Recurrent DIPG
DrugACT001
Nationwide Children's Hospital
Phase 2
60
Randwick, South Brisbane, Melbourne, Perth
2025-07-10
Recruiting
Telethon Kids Institute
Phase 4
200
Perth
2025-06-25
Recruiting
XII Medical
Not applicable
30
Canberra, Sydney, Wollongong, Brisbane, Perth
2025-06-24
Recruiting
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
NCT07082803Lymphoma, Lymphoma, Non Hodgkin
DrugZeprumetostat
Treeline Biosciences, Inc.
Phase 1
180
Macquarie Park, Woolloongabba, Malvern, Melbourne, Perth
2025-06-23
Active, closed
Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
NCT06984094RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection
Clover Biopharmaceuticals AUS Pty
Phase 1/2
612
Adelaide, Melbourne, Perth
2025-06-18
Active, closed
Atridia Pty Ltd.
Phase 1
25
Sydney, Adelaide, Brisbane, Melbourne, Perth, Wollongong
2025-06-15
Recruiting
The University of Western Australia
Observational
100
Perth
2025-06-12
Recruiting
National Cancer Institute (NCI)
Phase 2
222
Hunter Regional Mail Centre, South Brisbane, Parkville, Perth
2025-05-30
Recruiting
Bambusa Therapeutics
Phase 1
286
Perth, Brisbane
2025-05-08
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Blacktown, Camperdown, Kogarah, Waratah, South Brisbane, Melbourne, Perth
2025-05-06
Recruiting
LaNova Medicines Limited
Phase 1/2
87
Ryde, Wollongong, Perth
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Adelaide, Birtinya, Brisbane, Douglas, Melbourne, Perth, Sydney
2025-05-05
Recruiting
SPYRAL GEMINI Pilot Study
NCT06907147Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
175
Perth
2025-05-01
Recruiting
Centervue SpA
Not applicable
380
Perth
2025-04-23
Recruiting
AP Biosciences Inc.
Phase 1/2
85
Macquarie, Bedford Park, Perth
2025-04-22
Not yet open
Predicting Outcomes Using Infra-red SEnsors, a Feasibility Study.
NCT06515080General Anesthetic Drug Adverse Reaction
Uppsala University
Observational
500
Perth
2025-03-31
Recruiting
Eli Lilly and Company
Phase 3
700
Auchenflower, Birtinya, Heidelberg, Kurralta Park, North Tamworth, Perth, Shepparton, Traralgon
2025-03-27
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Macquarie University, Perth
2025-03-11
Recruiting
AstraZeneca
Phase 3
5,000
Adelaide, Darlinghurst, Elizabeth Vale, Gosford, North Tamworth, Perth, Southport, St Leonards
2025-03-03
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
4,000
Melbourne, Perth
2025-03-01
Not yet open
University Hospital, Antwerp
Observational
120
Perth
2025-03
Recruiting
Bambusa Therapeutics
Phase 1
237
Fremantle, Perth
2025-02-27
Recruiting
Study of Olutasidenib and Temozolomide in HGG
NCT06161974High Grade Glioma, Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV
DrugOlutasidenib
Rigel Pharmaceuticals
Phase 2
60
Randwick, South Brisbane, Perth
2025-02-01
By invitation
Pharvaris Netherlands B.V.
Phase 3
170
Box Hill, Parkville, Perth, Sydney
2025-02-01
Active, closed
AbbVie
Phase 1
4
Sydney, Southport, Heidelberg, Perth
2025-01-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Townsville, Adelaide, Ballarat, Melbourne, Perth
2025-01-27
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06789172Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer
DrugFamotidine
Epkin
Phase 1
146
Sydney, Perth
2025-01-23
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Blacktown, Cooloongup, Epping, Heidelberg, Kingswood, Liverpool, Melbourne, Perth
2025-01-22
Active, closed
Stemline Therapeutics, Inc.
Phase 2
85
Concord, Douglas, Adelaide, Box Hill, Clayton, Fitzroy, Heidelberg, Perth
2025-01-14
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
NCT06656494Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
DrugsICP-248·Azacitidine
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1
266
Sydney, Perth
2024-12-18
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
1,714
Westmead, Brisbane, Southport, Parkville, Perth
2024-12-18
Recruiting
SEALion: Study on Supplemental Oxygenation Via Nasal Cannula for Young Children During Intubation
NCT06683599Difficult Airway, Difficult Airway Intubation, Neonate
Vinícius C Quintão, MD, MSc, PhD
Not applicable
240
Perth
2024-12-10
Active, closed
Genmab
Phase 3
191
Camperdown, Sydney, Southport, Bedford Park, Perth, Subiaco, Fitzroy, Wendouree
2024-11-25
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer
DrugsTORL-1-23·Pegfilgrastim
TORL Biotherapeutics, LLC
Phase 2
230
Clayton, Blacktown, Chermside, Bedford Park, Perth
2024-11-20
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Concord, Kingswood, Liverpool, Westmead, Clayton, Heidelberg, Parkville, Perth
2024-11-12
Recruiting
Telix Pharmaceuticals (Innovations) Pty Ltd
Phase 1
50
Brisbane, Melbourne, Perth
2024-10-31
Recruiting
Murdoch Childrens Research Institute
Phase 2
232
Sydney, Brisbane, Melbourne, Perth
2024-10-29
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
NCT06368817Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma, Pineal Region Germinoma
DrugsParaplatin·Etoposide·Carboplatin
Children's Oncology Group
Phase 2
240
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2024-10-22
Recruiting
Jubilant Therapeutics Inc.
Phase 1/2
30
Sydney, Adelaide, Melbourne, Perth, Nedlands
2024-10-21
Recruiting
LaNova Medicines Limited
Phase 1/2
108
Perth
2024-10-09
Recruiting
GlaxoSmithKline
Phase 2
393
Adelaide, Melbourne, Parkville Melbourne, Murdoch, Perth
2024-09-27
Recruiting
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
NCT05843253High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Glioblastoma
DrugsEverolimus·Ribociclib·Temozolomide
Nationwide Children's Hospital
Phase 2
120
Randwick, South Brisbane, Melbourne, Perth
2024-08-22
Active, closed
Medinol Ltd.
Not applicable
30
Melbourne, Perth, Sydney
2024-08-15
Active, closed
Genmab
Phase 3
379
Garran, Sydney, Wollongong, Toowoomba, Clayton, Perth
2024-08-13
Recruiting
AbbVie
Phase 3
110
Randwick, Westmead, South Brisbane, Clayton, Perth
2024-08-08
Recruiting
AbbVie
Phase 3
170
Waratah, Townsville, Fitzroy, Perth
2024-08-05
Recruiting
Targeted Pediatric High-Grade Glioma Therapy
NCT05839379High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Glioblastoma
Nationwide Children's Hospital
Observational
350
Randwick, South Brisbane, Melbourne, Perth
2024-08-02
Recruiting
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
520
Sydney, Wollongong, Melbourne, Perth, Brisbane, East Maitland, Heidelberg, Malvern
2024-07-26
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Bedford Park, Herston, Kurralta Park, Melbourne, Perth, Woolloongabba, QLD
2024-07-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Westmead, Adelaide, Clayton, Heidelberg, Perth
2024-07-16
Recruiting
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
NCT06208657Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Recurrent Cancer
DrugsPaxalisib·Opdualag·Temozolomide·Irinotecan
Australian & New Zealand Children's Haematology/Oncology Group
Phase 1/2
90
Newcastle, Sydney, Brisbane, Adelaide, Hobart, Melbourne, Perth
2024-07-10
Recruiting
Sanofi
Phase 1
96
Camperdown, Townsville, Adelaide, Melbourne, Perth
2024-07-08
Recruiting
A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS
NCT06372717Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts, Acute Myeloid Leukemia, in Relapse
Apollo Therapeutics Ltd
Phase 1
100
Clayton, Fitzroy, Melbourne, Nedlands, Perth
2024-06-04
Recruiting
Eli Lilly and Company
Phase 3
300
Adelaide, Coorparoo, Perth, Sydney
2024-06-03
Recruiting
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
NCT05892510Ischemic Stroke, Acute, Cerebrovascular Disorders, Brain Disorder, Central Nervous System Diseases
University of Melbourne
Phase 2/3
462
Gold Coast, Adelaide, Melbourne, Perth, Sydney, Townsville
2024-06-01
Recruiting
Lomond Therapeutics Holdings, Inc.
Phase 1
150
Melbourne, Perth
2024-05-29
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Adelaide, Fitzroy, Greenslopes, Heidelberg, Herston, Murdoch, Perth, South Brisbane
2024-05-24
Active, closed
Syndax Pharmaceuticals
Phase 1
96
Epping, Perth, Adelaide, Melbourne, Nedlands
2024-05-21
Recruiting
W.L.Gore & Associates
Observational
2,000
New Lambton Heights, Southport, Bedford Park, Melbourne, Perth, Sydney
2024-05-07
Recruiting
University of Birmingham
Phase 2/3
210
Sydney, Brisbane, Perth
2024-05-02
Recruiting
National Cancer Institute (NCI)
Phase 3
478
Randwick, Westmead, South Brisbane, Parkville, Perth
2024-04-19
Active, closed
Takeda
Phase 2
213
Sydney, South Brisbane, Bedford Park, Woodville, Melbourne, Nedlands, Perth, Murdoch
2024-03-29
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Canberra, Clayton, Concord, Herston, Liverpool, Perth, Southport, St Albans
2024-03-29
Active, closed
AstraZeneca
Phase 3
2,554
Birtinya, Clayton, Darlinghurst, Gosford, Kogarah, Perth, St Leonards, Wollongong
2024-03-29
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
NCT05828069Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
DrugTovorafenib
National Cancer Institute (NCI)
Phase 2
48
Randwick, South Brisbane, Parkville, Perth
2024-03-28
Recruiting
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
180
Adelaide, Clayton, Melbourne, Perth
2024-03-26
Active, closed
ADARx Pharmaceuticals, Inc.
Phase 1
28
Adelaide, Nedlands, Perth
2024-03-21
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Brisbane, Herston, South Brisbane, Adelaide, Bedford Park, Clayton, Heidelberg, Perth
2024-03-13
Recruiting
Takeda
Phase 2
268
Concord, South Brisbane, Bedford Park, Woodville, Footscray, Murdoch, Perth, Epping
2024-03-05
Recruiting
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
NCT05910827Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma
DrugsHMBD-001·Cetuximab·Docetaxel
Hummingbird Bioscience
Phase 1/2
398
Sydney, Westmead, Brisbane, Greenslopes, Adelaide, Frankston, Malvern, Perth
2024-02-05
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Campbelltown, Liverpool, Adelaide, Perth
2024-02-05
Recruiting
Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia
NCT06166706Mechanical Ventilation Complication, Pediatric ALL, Pulmonary Complication, Perioperative/Postoperative Complications
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
10,000
Perth
2024-01-29
Recruiting
CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
NCT05804188Intubation Complication, Adverse Events
Thomas Riva
Observational
105,000
Perth
2024-01-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Camperdown, Liverpool, St Leonards, Waratah, Adelaide, Clayton, Melbourne, Perth
2023-12-31
Recruiting
Eli Lilly and Company
Phase 3
1,264
Adelaide, Auchenflower, Ballarat Central, Birtinya, Gosford, Mackay, Melbourne, Perth
2023-12-21
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Gosford, Perth, Westmead
2023-12-20
Recruiting
Intellia Therapeutics
Phase 3
1,200
Garran, Westmead, Cairns, Box Hill, Perth, Adelaide, Melbourne, Woolloongabba
2023-12-13
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Camperdown, Birtinya, Brisbane, South Brisbane, Southport, West Mackay, Clayton, Perth
2023-12-11
Recruiting
Thomas Riva
Not applicable
1,192
Perth
2023-12-01
Active, closed
AstraZeneca
Phase 3
1,835
Gosford, Meadowbrook, Perth, Reservoir, Southport
2023-11-07
Active, closed
AbbVie
Phase 3
122
Westmead, South Brisbane, Clayton, Perth
2023-11-06
Active, closed
IDEAYA Biosciences
Phase 2/3
420
Sydney, Brisbane, Melbourne, Perth, Adelaide
2023-10-31
By invitation
Eledon Pharmaceuticals
Phase 2
132
Adelaide, Perth
2023-10-25
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
DrugsSonrotoclax·Zanubrutinib
BeOne Medicines
Phase 2
114
Concord, St Leonards, Woolloongabba, Bedford PK, Clayton, Fitzroy, Nedlands, Perth
2023-10-23
Recruiting
Arkansas Children's Hospital Research Institute
Not applicable
420
Perth
2023-09-08
Recruiting
Hoffmann-La Roche
Phase 3
230
Blacktown, Darlinghurst, Gosford, Sippy Downs, Clayton, Perth
2023-09-08
Active, closed
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
NCT05919537Non-Small Cell Lung Cancer, Pancreatic Cancer, Locally Advanced Solid Tumor, Metastatic Solid Tumor
DrugsHMBD-001·Nab-paclitaxel·Docetaxel·Gemcitabine
Hummingbird Bioscience
Phase 1
68
Sydney, Brisbane, Adelaide, Malvern, Perth
2023-09-06
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
NCT05365659B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma
Iksuda Therapeutics Ltd.
Phase 1
140
Westmead, Adelaide, Hobart, Perth
2023-09-05
Active, closed
Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
NCT05788081Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV
DrugsGolcadomide·Opdivo·Rituximab·Nivolumab
Olivia Newton-John Cancer Research Institute
Phase 2
40
Ballarat, Box Hill, Geelong, Heidelberg, Perth
2023-08-31
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
DrugOlverembatinib
Ascentage Pharma Group Inc.
Phase 3
350
St Leonards, Adelaide, Melbourne, Perth
2023-08-31
Recruiting
Oticara Australia PTY LTD
Phase 2
24
Sydney, Brisbane, Adelaide, Perth
2023-08-17
Active, closed
Erasca, Inc.
Phase 1
86
Macquarie Park, Melbourne, Perth
2023-08-17
Recruiting
University of Sydney
Phase 3
300
Sydney, Brisbane, Melbourne, Perth
2023-08-02
Recruiting
Lin BioScience, Inc
Phase 1/2
90
Wollongong, Benowa, Adelaide, Melbourne, Nedlands, Perth
2023-07-20
Active, closed
Mineralys Therapeutics Inc.
Phase 3
1,076
Gosford, Castle Hill, Perth, Sippy Downs, Taringa
2023-07-14
Recruiting
Telethon Kids Institute
Observational
5,000
Douglas, Perth, Adelaide, Tiwi
2023-06-26
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
23
Brisbane, Clayton, Parkville, Perth
2023-06-16
Recruiting
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
NCT05868174Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 1
36
North Ryde, Adelaide, Brisbane, Melbourne, Perth
2023-05-23
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
NCT05826535Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Large B-cell Lymphoma
DrugsRondecabtagene autoleucel·Fludarabine·Cyclophosphamide
Lyell Immunopharma, Inc.
Phase 1/2
270
Nedlands, Perth, Melbourne
2023-05-09
Recruiting
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
NCT05286788Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
DrugBinimetinib
Nationwide Children's Hospital
Phase 2
38
Randwick, South Brisbane, Perth
2023-04-10
Recruiting
Wake Forest University Health Sciences
Observational
600
Perth
2023-03-28
Active, closed
Genmab
Phase 3
900
Liverpool, Adelaide, Clayton, Heidelberg, Melbourne, Nedlands, Perth
2023-02-08
Recruiting
Monash University
Phase 4
9,180
Sydney, Brisbane, Adelaide, Hobart, Melbourne, Nedlands, Perth
2023-02-07
Active, closed
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
DrugIMGN151
AbbVie
Phase 1
256
Perth
2023-01-11
Active, closed
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
DrugGSK4532990
GlaxoSmithKline
Phase 2
284
Nedlands, Perth
2023-01-02
Recruiting
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
NCT05233397Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
DrugTocilizumab
Nationwide Children's Hospital
Phase 2
30
Randwick, South Brisbane, Perth
2022-12-16
Recruiting
Precision Medicine for Every Child With Cancer
NCT05504772Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Childhood Leukemia
Australian & New Zealand Children's Haematology/Oncology Group
Observational
3,500
Adelaide, Brisbane, Hobart, Melbourne, Newcastle, Perth, Sydney
2022-12-16
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Clayton, Adelaide, New Lambton Heights, Parkville, Perth, South Brisbane, Sydney, Westmead
2022-12-15
Recruiting
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
NCT05562505Mechanical Ventilation Complication, Hypoxemia, Acute Respiratory Distress Syndrome Due to COVID-19, COVID-19 Respiratory Infection
Australian and New Zealand Intensive Care Research Centre
Not applicable
140
Darlinghurst, Sydney, Brisbane, Gold Coast, Melbourne, Perth
2022-11-28
Recruiting
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
NCT05504291Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Group D Retinoblastoma, Stage I Retinoblastoma
DrugsVincrystine·Melphalan·Paraplatin·Vincristine
Children's Oncology Group
Phase 2
26
Parkville, Perth
2022-11-04
Recruiting
Canadian Cancer Trials Group
Phase 2
84
Concord, Nowra, Wollongong, Adelaide, Heidelberg, Perth
2022-11-01
Active, closed
Amicus Therapeutics
Phase 3
14
Parkville, Perth
2022-10-31
Recruiting
4D Molecular Therapeutics
Phase 1/2
18
Melbourne, Perth, Westmead
2022-10-16
Active, closed
Genmab
Phase 1
17
Westmead, Parkville, Perth
2022-10-04
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Adelaide, Fitzroy, Liverpool, Murdoch, Newtown, North Terrace, Parkville, Perth
2022-09-27
Active, closed
Genmab
Phase 3
549
Camperdown, Kingswood, Douglas, Frankston, Murdoch, Perth
2022-09-20
Recruiting
Yuhan Corporation
Phase 1/2
147
Adelaide, Melbourne, Perth, Sydney
2022-08-26
Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
NCT05304585Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma
DrugsDactinomycin·Vincrystine·Cytoxan·Vincristine
Children's Oncology Group
Phase 3
205
Randwick, Westmead, Perth
2022-08-04
Active, closed
Phase III Trial of Sirolimus in IBM
NCT04789070Inclusion Body Myositis
DrugsRapamycin·Sirolimus
University of Kansas Medical Center
Phase 3
140
Sydney, Brisbane, Adelaide, Melbourne, Perth
2022-07-01
Recruiting
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
NCT04876131Complicated Urinary Tract Infection, Infection, Pediatric Infectious Disease
Murdoch Childrens Research Institute
Phase 4
396
Adelaide, Geelong, Melbourne, Parkville, Perth
2022-05-30
Recruiting
PedAL BCU, LLC
Phase 1/2
960
Westmead, South Brisbane, Parkville, Perth
2022-04-18
Active, closed
Bausch Health Americas, Inc.
Phase 3
524
Concord, Kingswood, Bedford Park, Box Hill, Parkville, Murdoch, Perth
2022-04-07
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
NCT05235165Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma, Osteosarcoma
Children's Oncology Group
Phase 3
62
Westmead, Parkville, Perth
2022-04-01
Recruiting
Pfizer
Phase 2
91
Liverpool, Mount Kuring-Gai, Waratah, Bedford Park, Kurralta Park, Melbourne, Perth
2022-02-02
Active, closed
OncoBeta Therapeutics
Not applicable
210
Sydney, Tugun, Perth
2022-01-17
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Townsville, Ballarat, Perth
2022-01-14
Active, closed
JOTEC GmbH
Observational
30
Melbourne, Perth, Saint Leonards, Southport
2022-01-01
Recruiting
Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease
NCT05136222Motor Neuron Disease / Amyotrophic Lateral Sclerosis
University of Melbourne
Not applicable
244
Adelaide, Brisbane, Canberra, Melbourne, Perth, Sydney
2021-12-15
Recruiting
Copenhagen University Hospital, Rigshospitalet
Phase 2/3
336
Perth
2021-10-25
Active, closed
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
NCT05198674Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
1,899
Melbourne, Perth
2021-10-20
Active, closed
National Cancer Institute (NCI)
Phase 3
244
Hunter Regional Mail Centre, Westmead, South Brisbane, Parkville, Perth
2021-10-05
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Adelaide, Frankston, Hobart, Melbourne, Perth
2021-09-20
Recruiting
BeOne Medicines
Phase 1/2
246
Garran, Kingswood, Clayton, Fitzroy, Melbourne, Perth
2021-09-16
Active, closed
Celgene
Phase 1
224
Adelaide, Perth
2021-09-15
Active, closed
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
NCT04994132Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Metastatic Embryonal Rhabdomyosarcoma
DrugsDactinomycin·Vinorelbine·Cytoxan·Vincristine
Children's Oncology Group
Phase 3
113
Hunter Regional Mail Centre, Randwick, Westmead, Parkville, Perth
2021-09-14
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
110
Westmead, Brisbane, Clayton, Perth
2021-08-19
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Waratah, Wollstonecraft, Southport, Heidelberg, Perth
2021-08-04
Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
NCT04684368Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma, Immature Teratoma
DrugsUromitexan·Tripegfilgrastim·Mesna·Isophosphamide
Children's Oncology Group
Phase 2
160
Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2021-07-13
Recruiting
HighLife SAS
Not applicable
30
Auchenflower, Perth, Sydney
2021-07-01
Recruiting
Nutrition in Paediatric Critical Care
NCT06695078ICU, Nutrition, Paediatric
Australian and New Zealand Intensive Care Research Centre
Observational
200
Adelaide, Brisbane, Hobart, Melbourne, Perth, Sunshine Coast, Sydney
2021-06-07
Recruiting
BonE and Joint Infections - Simplifying Treatment in Children Trial
NCT04538053Bone Infection, Septic Arthritis, Bone and Joint Infection, Osteomyelitis
DrugCefazolin
Murdoch Childrens Research Institute
Phase 4
285
Kingswood, New Lambton Heights, Sydney, Darwin, Brisbane, Adelaide, Melbourne, Perth
2021-06-01
Recruiting
Janssen Research & Development, LLC
Phase 1/2
420
Clayton, Perth, Southport
2021-05-19
Recruiting
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
NCT04774159Peripheral Arterial Disease, Atherosclerosis of Extremities, Inflammation
DrugColchicine
Population Health Research Institute
Phase 3
6,150
Perth, Box Hill
2021-05-06
Active, closed
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04320888Hematopoietic and Lymphatic System Neoplasm, Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma
DrugSelpercatinib
National Cancer Institute (NCI)
Phase 2
1
Perth
2021-05-03
Recruiting
Day One Biopharmaceuticals, Inc.
Phase 2
141
Brisbane, Parkville, Perth, Randwick, Westmead
2021-04-22
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Kogarah, Hobart, Nedlands, Perth, Auchenflower
2021-04-08
Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
NCT04655404High Grade Glioma, Diffuse Intrinsic Pontine Glioma
DrugLarotrectinib
Nationwide Children's Hospital
Early Phase 1
15
Randwick, South Brisbane, Perth
2021-04-08
Active, closed
ALX Oncology Inc.
Phase 2
189
Sydney, Brisbane, Melbourne, Perth, Windsor Gardens
2021-04-02
Recruiting
Boston Scientific Corporation
Observational
5,000
Perth, St Leonards
2021-03-29
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Garran, Darlinghurst, Kogarah, Liverpool, Wentworthville, Melbourne, Perth
2021-03-09
Recruiting
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
NCT04502394Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
DrugsNavtemadlin·Acalabrutinib
Kartos Therapeutics, Inc.
Phase 1/2
84
Adelaide, Box Hill, Geelong, Perth
2021-02-23
Recruiting
International CDKL5 Clinical Research Network
NCT05558371CDKL5, CDKL5 Deficiency Disorder, CDD
University of Colorado, Denver
Observational
1,000
Perth
2021-02-15
Active, closed
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
NCT05388708Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation
University of Michigan
Observational
550
Melbourne, Perth, South Brisbane, Westmead
2021-02-04
Active, closed
Children's Oncology Group
Phase 2
41
Westmead, South Brisbane, Parkville, Perth
2020-12-31
Recruiting
National Cancer Institute (NCI)
Phase 2
461
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Perth
2020-12-17
Active, closed
Janssen Research & Development, LLC
Phase 1/2
228
Fitzroy, Perth
2020-12-15
Recruiting
FS222 First in Human Study in Patients With Advanced Malignancies
NCT04740424Advanced Cancer, Metastatic Cancer
invoX Pharma Limited
Phase 1
260
Waratah, Perth
2020-12-14
Active, closed
AbbVie
Phase 1
21
Douglas, Hobart, Perth
2020-11-11
Recruiting
Study to Evaluate the Safety and Tolerability of EP0042
NCT04581512Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
DrugsAzacitidine·Venetoclax
Ellipses Pharma
Phase 1/2
70
Perth
2020-11-02
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
NCT04322318Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor, Stage II Kidney Wilms Tumor, Stage III Kidney Wilms Tumor
DrugsIsophosphamide·Vincrystine·Ifosfamide·Topotecan
Children's Oncology Group
Phase 2
256
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2020-10-19
Active, closed
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
NCT04195399Desmoid Fibromatosis, Recurrent Desmoid Fibromatosis, Unresectable Desmoid Fibromatosis
DrugNirogacestat
Children's Oncology Group
Phase 2
31
Westmead, South Brisbane, Perth
2020-10-07
Active, closed
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
NCT04323046Glioblastoma, Malignant Glioma, Recurrent Glioblastoma, Recurrent Malignant Glioma
DrugsOpdivo·Nivolumab
Sabine Mueller, MD, PhD
Phase 1
9
Sydney, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2020-10-02
Recruiting
University of Birmingham
Phase 1/2
1,672
Brisbane, Camperdown, Clayton, Melbourne, New Lambton Heights, Perth, Sydney, Westmead
2020-09-17
Active, closed
AbbVie
Phase 3
330
Darlinghurst, East Albury, Waratah, Melbourne, Perth
2020-08-31
Active, closed
Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA
NCT04325022Advanced Degeneration of the Hip Joint, Revision of the Hip Joint
Smith & Nephew, Inc.
Observational
177
Brisbane, Perth, Deakin
2020-07-27
Recruiting
Children's Oncology Group
Phase 3
1,400
Randwick, Westmead, South Brisbane, Perth
2020-07-21
Active, closed
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
NCT04195555Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma, Recurrent Langerhans Cell Histiocytosis
DrugIvosidenib
National Cancer Institute (NCI)
Phase 2
3
Perth
2020-07-20
Active, closed
Eli Lilly and Company
Phase 1
71
Perth
2020-06-11
Active, closed
Åslaug Helland
Phase 2
118
Perth
2020-05-04
Recruiting
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
NCT04310930Pulmonary Disease Due to Mycobacteria (Diagnosis)
DrugsImipenem·Co-trimoxazole·Rifabutin·Tigecycline
The University of Queensland
Phase 2/3
300
Kogarah, South Brisbane, Woolloongabba, Heidelberg, Parkville, Perth, Adelaide, Birtinya
2020-03-02
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
3,000
Sydney, Brisbane, Adelaide, Melbourne, Richmon, St Albans, Perth
2020-03-01
Active, closed
Loxo Oncology, Inc.
Phase 3
291
St Leonards, Melbourne, Perth
2020-02-11
Active, closed
Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study
NCT04536870Heart Failure, Atrial Fibrillation, Healthy Ageing, Hypercholesterolemia
Monash University
Not applicable
369
Melbourne, Perth
2019-12-12
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
East Albury, Tweed Heads, East Melbourne, Frankston, Geelong, Heidelberg, Perth
2019-11-13
Active, closed
Children's Oncology Group
Phase 2
110
Hunter Regional Mail Centre, Westmead, Clayton, Parkville, Perth
2019-11-08
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
NCT03959085B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Central Nervous System Leukemia, Mixed Phenotype Acute Leukemia
DrugsCalaspargase Pegol·Tioguanin·Thioguanine·Oncaspar
Children's Oncology Group
Phase 3
5,951
Hunter Regional Mail Centre, Westmead, South Brisbane, North Adelaide, Saint Hobart, Clayton, Parkville, Perth
2019-10-31
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Camberwell, Clayton, Footscray, Murdoch, Perth, South Brisbane, Subiaco, Woolloongabba
2019-09-26
Recruiting
Melanoma Institute Australia
Phase 2
218
Sydney, Waratah, Wollstonecraft, Woolloongabba, Adelaide, East Melbourne, Melbourne, Perth
2019-08-14
Active, closed
OncoVerity, Inc.
Phase 2
103
Darlinghurst, Fitzroy, Melbourne, Perth, Westmead
2019-07-29
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Blacktown, Camperdown, Heidelberg, Kogarah, North Melbourne, Perth, Wollongong
2019-07-09
Active, closed
Children's Oncology Group
Phase 2
94
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2019-07-08
Active, closed
National Cancer Institute (NCI)
Phase 3
6,720
Hunter Regional Mail Centre, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2019-07-03
Recruiting
Lumbar Brace Deployment in the Emergency Department for Benign Low Back Pain
NCT03829631Low Back Pain, Brace, Emergencies, Pain
University of Alberta
Not applicable
152
Perth
2019-06-12
Active, closed
PROSpect: Prone and Oscillation Pediatric Clinical Trial
NCT03896763Acute Respiratory Distress Syndrome in Children
University of Pennsylvania
Not applicable
600
Perth, Sydney
2019-05-01
Recruiting
Eli Lilly and Company
Phase 3
190
Melbourne, Perth, Westmead
2019-04-05
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
NCT05685745Infant, Extremely Premature, Obstetric Labor, Premature, Premature Birth, Intensive Care, Neonatal
The University of Texas Health Science Center, Houston
Observational
5,000
South Brisbane, Heidelberg, Parkville, Perth
2019-01-01
Active, closed
Idorsia Pharmaceuticals Ltd.
Phase 3
107
Parkville, Perth
2018-12-18
Active, closed
Children's Oncology Group
Phase 2
38
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Clayton, Parkville, Perth
2018-11-06
Active, closed
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
NCT03533582Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma, Hepatoblastoma
DrugsSorafenib·Cis-platinum·CDDP·Paraplatin
Children's Oncology Group
Phase 3
537
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2018-05-24
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
South Brisbane, Bedford Park, Frankston, Melbourne, Perth
2018-05-03
Active, closed
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
NCT03213652Advanced Malignant Solid Neoplasm, Malignant Solid Neoplasm, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
DrugEnsartinib
National Cancer Institute (NCI)
Phase 2
13
Perth
2018-04-17
Active, closed
AbbVie
Phase 2
156
Darlinghurst, Kogarah, Adelaide, Box Hill, Fitzroy Melbourne, Melbourne, Perth
2018-04-02
Active, closed
Children's Oncology Group
Phase 2
45
Hunter Regional Mail Centre, North Adelaide, Perth
2017-11-17
Active, closed
DePuy Orthopaedics
Not applicable
400
Fremantle, Perth
2017-09-19
Active, closed
Global Fenestrated Anaconda Clinical STudy
NCT03180996Abdominal Aortic Aneurysm
Vascutek Ltd.
Observational
160
Melbourne, Perth
2017-09-11
Active, closed
PRecISion Medicine for Children With Cancer
NCT03336931Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Childhood Leukemia
Sydney Children's Hospitals Network
Observational
550
Newcastle, Sydney, Brisbane, Adelaide, Melbourne, Perth
2017-09-05
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Randwick, Westmead, Brisbane, Adelaide, Bedford Park, Parkville, Perth
2017-08-10
Active, closed
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T Acute Lymphoblastic Leukemia
DrugsL-leucovorin·Therapeutic Hydrocortisone·Levofolinate·Isophosphamide
Children's Oncology Group
Phase 3
352
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Perth
2017-08-08
Active, closed
National Cancer Institute (NCI)
Phase 2
1,377
Perth
2017-07-31
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Sydney, Melbourne, Perth
2017-06-26
Active, closed
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
NCT03057626Recurrent Neuroblastoma, Stage 2A Neuroblastoma, Stage 2B Neuroblastoma, Stage 3 Neuroblastoma
Children's Oncology Group
Observational
376
Perth
2017-06-05
Active, closed
DePuy Orthopaedics
Not applicable
400
Gold Coast, Perth
2017-05-30
Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
NCT03067181Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor, Malignant Germ Cell Tumor
DrugsBleomycin·Cis-platinum·CDDP·Paraplatin
Children's Oncology Group
Phase 3
1,780
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Clayton, Parkville, Perth
2017-05-25
Active, closed
AbbVie
Phase 3
443
Woolloongabba, Adelaide, Melbourne, Parkville, Nedlands, Perth
2017-02-02
Active, closed
DBV Technologies
Phase 3
300
Brisbane, Perth, Sydney
2017-01-23
Active, closed
Celgene
Phase 1/2
130
Adelaide, Melbourne, Perth
2016-06-03
Active, closed
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
NCT02567435Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Rhabdomyosarcoma
DrugsTemsirolimus·Dactinomycin·Vinorelbine·Cytoxan
National Cancer Institute (NCI)
Phase 3
325
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Perth
2016-06-01
Active, closed
University of Birmingham
Phase 3
700
Adelaide, Brisbane, Melbourne, New Lambton Heights, Perth, Sydney, Westmead
2016-04
Active, closed
Movember Foundation
Not applicable
866
Brisbane, Melbourne, Perth
2016-01
Active, closed
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
NCT02521493Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome, Myeloid Leukemia Associated With Down Syndrome
DrugsL-Asp·Leucogen·L-Asparaginase·Asparaginase
Children's Oncology Group
Phase 3
280
Hunter Regional Mail Centre, Randwick, Westmead, Parkville, Perth
2015-12-23
Active, closed
Children's Oncology Group
Phase 3
158
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2015-07-21
Active, closed
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
NCT02099123Independent Living, Disability Free Survival, Elderly, Healthy
DrugsLipitor·Atorvastatin
Monash University
Phase 4
9,971
Hobart, Melbourne, Adelaide, Brisbane, Newcastle, Perth
2015-07
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Darlinghurst, Herston, Wooloongabba, Bedford Park, Box Hill, Clayton, Franston, Perth
2015-03-05
Active, closed
National Cancer Institute (NCI)
Phase 3
669
Perth
2014-12-17
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
Perth
2014-12-04
Active, closed
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
NCT02112916Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma, Ann Arbor Stage III Adult Lymphoblastic Lymphoma
DrugsHydrocortisone Sodium Succinate·Isophosphamide·Tioguanin·Thioguanine
National Cancer Institute (NCI)
Phase 3
847
Hunter Regional Mail Centre, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2014-10-04
Active, closed
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
NCT02176967Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neuroblastoma
DrugsDoxorubicin Hydrochloride·Adriamycin·Daunorubicin·Cytoxan
Children's Oncology Group
Phase 3
391
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Perth
2014-08-08
Active, closed
University Hospitals of Derby and Burton NHS Foundation Trust
Not applicable
1,900
Adelaide, Bankstown, Brisbane, Coffs Harbour, Melbourne, Perth, Wagga Wagga
2014-08-01
Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
NCT01790152Hodgkin Lymphoma in Remission, Leukemia in Remission, Lymphoblastic Lymphoma, Osteosarcoma
Children's Oncology Group
Observational
420
Perth
2014-03-05
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Adelaide, Coburg, Concord, Heidelberg, Melbourne, Perth, Prahran, Wahroonga
2013-09-09
Active, closed
St. Jude Children's Research Hospital
Phase 2
660
Randwick, Westmead, Brisbane, Melbourne, Perth
2013-06-23
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Melbourne, Perth, Randwick, South Brisbane, Sydney
2013-04
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Westmead, Melbourne, Perth, Parkville
2012-07
Active, closed
Eli Lilly and Company
Phase 2
110
Garran, Wodonga, Perth
2012-05-22
Recruiting
Dominantly Inherited Alzheimer Network (DIAN)
NCT00869817Alzheimer's Disease
Washington University School of Medicine
Observational
700
Sydney, Melbourne, Perth
2009-01
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Westmead, Brisbane, Adelaide, Parkville, Perth
2001-07-31
Rows per page Showing 1–295 of 295
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/perth

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 295 of those studies with a site in Perth.

How many clinical trials are recruiting in Perth?

174 of the 295 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 11 have not yet opened recruitment, 105 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Perth), 295 studies
PhaseStudiesRecruitingShare
Phase 3884729.8%
Phase 2603320.3%
Phase 1362112.2%
Observational311710.5%
Not applicable28159.5%
Phase 1/228239.5%
Phase 2/31083.4%
Phase 4852.7%
Early Phase 1652%

Most active sponsors

Lead sponsors with the most studies (Perth)
Lead sponsorStudiesRecruiting
Children's Oncology Group2310
National Cancer Institute (NCI)134
Eli Lilly and Company119
AbbVie103
AstraZeneca75
Nationwide Children's Hospital77
Merck Sharp & Dohme LLC63
Genmab50
Janssen Research & Development, LLC52
Telethon Kids Institute53
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.